Knowstox

Fundamentals snapshot

National HealthCare Corporation

NHC · ASE · Healthcare · Medical Care Facilities

Current price

$224.84

52-week range

$115.77 - $239.29

Market cap

$3.52B

One-glance verdict

Within fair range

$238.66 our estimate vs market $224.84

Balance sheet

Healthy

20.15x Strong cushion

Net cash $178.78M. Interest coverage shows how many times profit covers the interest bill.

What this company does

National HealthCare Corporation

National HealthCare Corporation provides a wide range of services for seniors, operating everything from skilled nursing homes to assisted living communities and at-home care agencies. The company makes money by providing long-term housing, medical support, and daily living assistance to older adults and patients recovering from illness. Because an aging population creates consistent demand for these essential services, the company’s business can be more stable and predictable than companies in other industries.

Price history

How the share price has moved

Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q3 $28.55M FY2024 Q4 $4.63M FY2025 Q1 $33.12M FY2025 Q2 $52.62M FY2025 Q3 $56.49M FY2025 Q4 $6.41M FY2026 Q1 $52.89M FY2026 Q2 $30.74M
Revenue $408.02M
Net income $40.32M
Diluted EPS 2.54
Operating cash flow $43.27M
Free cash flow $30.74M
Revenue $381.82M
Net income $35.86M
Diluted EPS 2.27
Operating cash flow $62.53M
Free cash flow $52.89M
Revenue $386.51M
Net income $24.85M
Diluted EPS 1.58
Operating cash flow $16.81M
Free cash flow $6.41M
Revenue $382.66M
Net income $39.24M
Diluted EPS 2.50
Operating cash flow $66.20M
Free cash flow $56.49M
Revenue $374.91M
Net income $23.72M
Diluted EPS 1.52
Operating cash flow $62.82M
Free cash flow $52.62M
Revenue $373.70M
Net income $32.20M
Diluted EPS 2.07
Operating cash flow $39.26M
Free cash flow $33.12M
Revenue $369.35M
Net income $6.08M
Diluted EPS 0.38
Operating cash flow $12.79M
Free cash flow $4.63M
Revenue $340.20M
Net income $42.79M
Diluted EPS 2.73
Operating cash flow $34.21M
Free cash flow $28.55M

Is it cheap or expensive?

Fair value $238.66 vs current price $224.84

Our most-likely fair value is $238.66 a share — about 6.1% away from today's price of $224.84, so the stock currently looks fairly priced.

fair

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 4.0% · Discount 7.2% · Terminal 2.5%

$238.66

Bear

Growth 2.5% · Discount 7.2% · Terminal 2.5%

$219.27

Bull

Growth 7.0% · Discount 7.2% · Terminal 2.5%

$282.59

Is it drowning in debt?

Healthy

Net cash $178.8M - more cash than debt. Interest coverage 20.1x.

Net debt $-178.78M
Interest coverage 20.15x

National HealthCare Corporation's profit covers its interest bill about 20.1 times over. which is stronger than most peers shown here and 2 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.

Healthy
Worse cushion Baseline Better cushion
NHC BASELINE National HealthCare Corporation

Total debt $31.41M Interest coverage 20.15x This is the baseline the peer rows are being compared against.

Total debt $2.25B Interest coverage 53.24x +164% vs NHC Carries about 2.6x more debt cushion than NHC.

Total debt $5.49B Interest coverage 0.36x -98% vs NHC Carries about 55.4x less debt cushion than NHC.

Total debt $3.40B Interest coverage 10.92x -46% vs NHC Carries about 1.8x less debt cushion than NHC.

Total debt $1.57B Interest coverage -0.35x -100% vs NHC This peer has almost no interest-payment cushion compared with NHC.

Total debt $495.55M Interest coverage 7.62x -62% vs NHC Carries about 2.6x less debt cushion than NHC.

What you should know

The case for and against NHC

3 Rewards 2 Risks

Rewards

  • Revenue grew 2.7% last year.
  • Returns 13.3% on equity, ahead of 50% of its peers.
  • Free cash flow was positive in 9/10 years.

Risks

  • Forward P/E (522.9x) is higher than trailing (25.3x) - earnings are expected to drop.
  • Stock trades 4.5% above its 5-year average P/E.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
25.26x
Forward P/E
522.88x
P/B
3.14x
P/S
2.26x
EV/EBITDA
17.59x
PEG ratio
0.82x

Profitability

How much profit each dollar creates

Gross margin
39.5%
Operating margin
12.0%
Net margin
9.0%
ROE
13.3%
ROA
5.8%

Health

Liquidity and balance-sheet strength

Debt / equity
0.03x
Current ratio
1.86x
Quick ratio
1.47x
Total debt
$31.41M
Total cash
$210.19M

Growth

How the business has been compounding

Revenue TTM
$1.56B
Revenue 5Y CAGR
9.0%
EPS TTM
8.90
EPS 5Y CAGR
74.2%

Cash flow

How much cash the business throws off

Operating CF TTM
$188.81M
Free CF TTM
$148.63M
FCF margin
9.5%

Dividend

Shareholder payout

Yield
1.2%
Payout ratio
29.1%
Last ex-div date
2026-09-30